Thursday, July 18, 2019

Elevated Diabetes in Children Treated With Antipsychotics, Antidepressants

Researchers at the University of Massachusetts found that children are more than twice as likely to develop diabetes when treated with antidepressants, and more...

J&J Settles Texas Medicaid Lawsuit for $158 Million

Johnson & Johnson has agreed to settle Texas' lawsuit for the company's fraudulent marketing of Risperdal. The is the first time J&J has settled...

Texas Lawsuit Against J&J Underway

Texas' lawsuit against Johnson & Johnson for its off-label marketing of Risperdal, which the state alleges involved fraudulent claims about the drug's safety and...

J & J to Pay More Than $1 Billion For Wrongful Marketing of Risperdal

In order to resolve a civil investigation into the marketing of Risperdal for unapproved uses, Johnson & Johnson will pay more than $1 billion...

Antipsychotic Drugs and the Risk of Hyperglycemia in Older Adults Without Diabetes: A Population-Based...

  Objective: To determine whether current antipsychotic use among older persons without diabetes is associated with a higher risk of hospital visits for hyperglycemia, as...

A Research Timeline for Antipsychotic Drugs

1883     Phenothiazines developed as synthetic dyes 1934     USDA develops phenothiazines as insecticides 1938     Phenothiazines used to kill swine parasites 1949  ...

Mad In America’s Chapters

Preface The World Health Organization has repeatedly found that people diagnosed with schizophrenia in the U.S. and other developed countries fare much worse than schizophrenia...

Antipsychotics and Chronic Illness

A. The Chronicity Problem Becomes Apparent (1960s-1979s) It seems paradoxical that drugs that ameliorate acute psychotic symptoms over the short term will increase the likelihood...

Polypharmacy/Bipolar illness

  A. Bipolar Illness Before the Psychopharmacology Era Prior to 1955, bipolar illness was a rare disorder. There were only 12,750 people  hospitalized with that disorder...

Outcomes in the Era of Atypical Antipsychotics

Once second-generation antipsychotic drugs came on the market (which are known as “atypicals”), there were claims by psychiatric researchers that they would lead to...

A Rorschach Test for Psych Drugs

On October 23, the New York Times ran a very nice feature story about a Los Angeles woman, Keris Myrick, who, even though she...

Drug Companies ‘Just Say No’ to Psych Drugs

The market for psychiatric drugs is, of course,  booming. In 2011, spending on psychiatric medications can expect to top $40 billion. Yet, in spite...

”Broken Brains” and “Beautiful Minds”

When I first interviewed Brandon Banks, in the spring of 2008, while researching Anatomy of an Epidemic, he had recently entered Elizabethtown Community College...

A Schizophrenia Mystery Solved?

One of the enduring mysteries in schizophrenia research circles has been the disparity in outcomes between schizophrenia patients in "developing countries" and those in...

Antipsychotics/Schizophrenia

The long-term outcomes literature for antipsychotics, which has been compiled over a period of nearly 50 years, consistently tells of drugs that increase the...

Follow Us

19,639FansLike
11,994FollowersFollow
3,102SubscribersSubscribe